COVID-19: Factors associated with psychological distress, fear, and coping strategies among community members across 17 countries.
COVID-19
coping
coronavirus
fear
mental health
psychological distress
resilience
Journal
Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734
Informations de publication
Date de publication:
01 10 2021
01 10 2021
Historique:
received:
28
06
2021
accepted:
20
09
2021
entrez:
2
10
2021
pubmed:
3
10
2021
medline:
7
10
2021
Statut:
epublish
Résumé
The current pandemic of COVID-19 impacted the psychological wellbeing of populations globally. We aimed to examine the extent and identify factors associated with psychological distress, fear of COVID-19 and coping. We conducted a cross-sectional study across 17 countries during Jun-2020 to Jan-2021. Levels of psychological distress (Kessler Psychological Distress Scale), fear of COVID-19 (Fear of COVID-19 Scale), and coping (Brief Resilient Coping Scale) were assessed. A total of 8,559 people participated; mean age (±SD) was 33(±13) years, 64% were females and 40% self-identified as frontline workers. More than two-thirds (69%) experienced moderate-to-very high levels of psychological distress, which was 46% in Thailand and 91% in Egypt. A quarter (24%) had high levels of fear of COVID-19, which was as low as 9% in Libya and as high as 38% in Bangladesh. More than half (57%) exhibited medium to high resilient coping; the lowest prevalence (3%) was reported in Australia and the highest (72%) in Syria. Being female (AOR 1.31 [95% CIs 1.09-1.57]), perceived distress due to change of employment status (1.56 [1.29-1.90]), comorbidity with mental health conditions (3.02 [1.20-7.60]) were associated with higher levels of psychological distress and fear. Doctors had higher psychological distress (1.43 [1.04-1.97]), but low levels of fear of COVID-19 (0.55 [0.41-0.76]); nurses had medium to high resilient coping (1.30 [1.03-1.65]). The extent of psychological distress, fear of COVID-19 and coping varied by country; however, we identified few higher risk groups who were more vulnerable than others. There is an urgent need to prioritise health and well-being of those people through well-designed intervention that may need to be tailored to meet country specific requirements.
Sections du résumé
BACKGROUND
The current pandemic of COVID-19 impacted the psychological wellbeing of populations globally.
OBJECTIVES
We aimed to examine the extent and identify factors associated with psychological distress, fear of COVID-19 and coping.
METHODS
We conducted a cross-sectional study across 17 countries during Jun-2020 to Jan-2021. Levels of psychological distress (Kessler Psychological Distress Scale), fear of COVID-19 (Fear of COVID-19 Scale), and coping (Brief Resilient Coping Scale) were assessed.
RESULTS
A total of 8,559 people participated; mean age (±SD) was 33(±13) years, 64% were females and 40% self-identified as frontline workers. More than two-thirds (69%) experienced moderate-to-very high levels of psychological distress, which was 46% in Thailand and 91% in Egypt. A quarter (24%) had high levels of fear of COVID-19, which was as low as 9% in Libya and as high as 38% in Bangladesh. More than half (57%) exhibited medium to high resilient coping; the lowest prevalence (3%) was reported in Australia and the highest (72%) in Syria. Being female (AOR 1.31 [95% CIs 1.09-1.57]), perceived distress due to change of employment status (1.56 [1.29-1.90]), comorbidity with mental health conditions (3.02 [1.20-7.60]) were associated with higher levels of psychological distress and fear. Doctors had higher psychological distress (1.43 [1.04-1.97]), but low levels of fear of COVID-19 (0.55 [0.41-0.76]); nurses had medium to high resilient coping (1.30 [1.03-1.65]).
CONCLUSIONS
The extent of psychological distress, fear of COVID-19 and coping varied by country; however, we identified few higher risk groups who were more vulnerable than others. There is an urgent need to prioritise health and well-being of those people through well-designed intervention that may need to be tailored to meet country specific requirements.
Identifiants
pubmed: 34598720
doi: 10.1186/s12992-021-00768-3
pii: 10.1186/s12992-021-00768-3
pmc: PMC8485312
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
117Informations de copyright
© 2021. The Author(s).
Références
PLoS One. 2020 Dec 11;15(12):e0243962
pubmed: 33306750
EClinicalMedicine. 2020 Dec;29:100630
pubmed: 33200120
Int J Environ Res Public Health. 2020 May 02;17(9):
pubmed: 32370116
J Public Health (Oxf). 2020 Aug 18;42(3):504-509
pubmed: 32436578
Global Health. 2020 Oct 8;16(1):95
pubmed: 33032629
PLoS One. 2021 Apr 1;16(4):e0249453
pubmed: 33793663
Int J Environ Res Public Health. 2020 Jun 29;17(13):
pubmed: 32610613
J Affect Disord. 2020 Oct 1;275:69-77
pubmed: 32658826
Psychol Med. 2003 Feb;33(2):357-62
pubmed: 12622315
PLoS One. 2020 Dec 31;15(12):e0244809
pubmed: 33382859
J Womens Health (Larchmt). 2020 Apr;29(4):465-466
pubmed: 32320331
Cyberpsychol Behav Soc Netw. 2021 Aug;24(8):521-525
pubmed: 33601944
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Psychopharmacol. 2010 Nov;24(4 Suppl):61-8
pubmed: 20923921
Int J Biol Sci. 2020 Aug 27;16(15):2828-2834
pubmed: 33061799
Front Psychol. 2021 Apr 06;12:601732
pubmed: 33889105
Int J Environ Res Public Health. 2020 Sep 30;17(19):
pubmed: 33007892
Brain Behav Immun. 2020 Aug;88:901-907
pubmed: 32437915
PLoS One. 2021 Feb 11;16(2):e0246824
pubmed: 33571297
Int J Ment Health Addict. 2020 Mar 27;:1-9
pubmed: 32226353
Sci Rep. 2021 May 13;11(1):10173
pubmed: 33986414
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Scand J Psychol. 2020 Oct;61(5):698-706
pubmed: 32567696
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Int J Environ Res Public Health. 2020 Jun 07;17(11):
pubmed: 32517294
J Psychiatr Res. 2021 Apr;136:103-108
pubmed: 33582608
BMC Public Health. 2021 Jan 9;21(1):104
pubmed: 33422039
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
J Behav Ther Exp Psychiatry. 2009 Mar;40(1):3-14
pubmed: 18417098
Int J Ment Health Nurs. 2021 Jun;30(3):747-758
pubmed: 33555128
Assessment. 2004 Mar;11(1):94-101
pubmed: 14994958
Arch Womens Ment Health. 2020 Dec;23(6):749-756
pubmed: 33068161